Marshall Wace’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-5,653
| Closed | -$81K | – | 2680 |
|
2022
Q1 | $81K | Sell |
5,653
-3,209
| -36% | -$46K | ﹤0.01% | 2489 |
|
2021
Q4 | $464K | Buy |
8,862
+7,017
| +380% | +$367K | ﹤0.01% | 2196 |
|
2021
Q3 | $108K | Buy |
+1,845
| New | +$108K | ﹤0.01% | 2275 |
|
2021
Q2 | – | Sell |
-2,713
| Closed | -$225K | – | 2102 |
|
2021
Q1 | $225K | Sell |
2,713
-1,423
| -34% | -$118K | ﹤0.01% | 1898 |
|
2020
Q4 | $314K | Buy |
+4,136
| New | +$314K | ﹤0.01% | 1502 |
|
2020
Q3 | – | Sell |
-11,174
| Closed | -$1.69M | – | 1529 |
|
2020
Q2 | $1.69M | Buy |
11,174
+7,624
| +215% | +$1.16M | 0.01% | 823 |
|
2020
Q1 | $296K | Buy |
+3,550
| New | +$296K | ﹤0.01% | 1085 |
|
2019
Q2 | – | Sell |
-1,514
| Closed | -$318K | – | 1310 |
|
2019
Q1 | $318K | Buy |
+1,514
| New | +$318K | ﹤0.01% | 1241 |
|
2018
Q2 | – | Sell |
-930
| Closed | -$213K | – | 700 |
|
2018
Q1 | $213K | Buy |
+930
| New | +$213K | 0.01% | 513 |
|